image
Healthcare - Biotechnology - NASDAQ - US
$ 9.68
-4.06 %
$ 2.89 B
Market Cap
-28.47
P/E
BALANCE SHEET
778 M ASSETS
7.42%
618 M LIABILITIES
2.76%
160 M EQUITY
30.17%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Amicus Therapeutics, Inc.
image
Current Assets 483 M
Cash & Short-Term Investments 286 M
Receivables 87.6 M
Other Current Assets 109 M
Non-Current Assets 295 M
Long-Term Investments 0
PP&E 58 M
Other Non-Current Assets 237 M
Current Liabilities 168 M
Accounts Payable 15.1 M
Short-Term Debt 16.6 M
Other Current Liabilities 136 M
Non-Current Liabilities 450 M
Long-Term Debt 437 M
Other Non-Current Liabilities 13.3 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2003
ASSETS
Cash & Cash Equivalents 247.0 148.8 245.2 163.2 142.8 79.7 49.1 187.0 69.5 24.1 43.6 34.0 25.7 29.6 19.3 28.1 44.2 12.1 6.4 0
Short Term Investments 39.2 144.8 237.3 320.0 309.9 424.4 309.5 143.3 144.5 127.6 38.4 65.2 30.0 77.9 58.9 93.1 117.3 42.6 18.0 0
Receivables 87.6 66.2 52.7 46.9 33.3 22.0 9.5 1.3 0 0 1.1 3.2 5.0 0 0 0 0 0 0 0
Inventory 59.7 23.8 26.8 19.6 14.0 8.4 4.6 3.4 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 49.5 40.2 69.7 59.4 40.0 33.2 38.6 10.0 5.1 5.8 5.2 4.5 5.9 4.5 4.5 4.9 3.0 0.3 0.4 0
Total Current Assets 483.1 423.8 596.8 579.5 520.1 551.1 392.0 340.1 216.6 154.6 88.3 104.6 66.6 109.7 80.5 123.6 163.0 55.0 24.9 0
PP&E 58.0 60.3 63.1 67.2 81.0 11.4 9.1 9.8 6.2 2.8 4.1 5.0 2.4 2.6 4.4 4.9 3.8 4.4 3.3 0
Intangible Assets 20.5 23.0 23.0 23.0 23.0 23.0 23.0 486.7 486.7 23.0 23.0 0 0 0 0 0 0 0 0 0
Goodwill 197.8 197.8 197.8 197.8 197.8 197.8 197.8 197.8 197.8 11.6 11.6 0 0 0 0 0 0 0 0 0
Long Term Investments 0 4.3 (4.9) (4.9) (5.1) (6.5) (6.5) (173.8) 0 17.5 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 18.6 10.0 24.4 19.1 28.3 6.7 5.2 2.5 1.1 0.5 0.6 0.4 0.7 0.3 0.5 0.3 0.3 0.3 0.5 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5
Total Assets 777.9 724.2 905.1 886.5 850.2 790.0 627.0 1 036.8 908.4 210.0 127.6 110.1 69.8 112.6 85.4 128.8 167.1 59.6 28.7 0.5
LIABILITIES
Accounts Payable 15.1 15.4 21.5 17.1 21.7 6.6 7.9 12.9 16.5 5.9 2.1 2.1 2.6 0 0 2.0 0.5 1.2 0.9 0
Short Term Debt 16.6 17.1 14.8 13.7 14.4 0 0.3 0.3 0 3.8 0.3 0.4 1.0 1.3 1.6 1.8 1.5 1.3 0.3 0
Other Current Liabilities 123.5 100.6 103.5 87.7 85.4 79.5 61.9 97.8 57.1 10.5 8.0 6.7 15.6 8.3 9.6 5.9 9.9 7.7 1.4 0
Total Current Liabilities 167.7 139.0 146.0 129.7 128.8 86.1 70.0 111.0 73.6 20.2 10.5 9.2 19.3 16.2 11.2 13.4 15.8 10.2 2.6 0
Long Term Debt 436.7 495.1 476.1 480.5 203.0 321.7 164.2 154.5 41.6 10.5 14.2 0.3 0 1.0 2.3 0.3 1.2 2.3 0.7 0
Deferred Tax Income 0 4.9 4.9 4.9 5.1 6.5 6.5 173.8 176.2 9.2 9.2 0 0 0 0 (44.0) (46.8) 0 0 0
Other Liabilities 13.3 (38.0) (29.2) (14.9) 36.9 32.7 33.5 237.5 269.1 47.9 48.0 31.3 1.9 4.7 0 0 0 124.7 61.2 0
Total Liabilities 617.7 601.1 597.8 600.1 373.8 447.0 274.2 676.7 560.5 87.8 81.8 40.9 40.2 47.6 13.5 57.7 63.8 137.2 64.5 5.8
EQUITY
Common Stock 2.9 2.8 2.8 2.6 2.6 1.9 1.7 1.5 1.3 1.0 0.7 0.6 0.4 0.4 0.3 0.3 0.3 70.3 K 40.4 K 0
Retained Earnings (2 684.1) (2 532.5) (2 295.9) (2 045.5) (1 768.6) (1 412.2) (1 063.6) (779.6) (579.6) (447.4) (378.5) (318.9) (270.1) (225.7) (170.8) (164.2) (124.8) (83.7) (37.3) (8.5)
Other Accumulative Comprehensive Income/Loss 5.3 (12.1) 5.0 8.2 2.8 68 K (2.1) 2.0 (0.1) (0.1) 1 K 14 K 4 K 28 K 43 K 0.5 0.4 14.8 K (2.6) 0
Total Equity 160.2 123.0 307.4 286.4 476.4 342.9 352.9 360.2 347.8 122.2 45.8 69.2 29.6 64.9 71.8 71.0 103.3 (77.5) (35.8) (5.3)
Total Liabilities and Equity 777.9 724.2 905.1 886.5 850.2 790.0 627.0 1 036.8 908.4 210.0 127.6 110.1 69.8 112.6 85.4 128.8 167.1 59.6 28.7 0.5
SHARES OUTSTANDING
Common Shares Outstanding 295.2 289.1 271.4 258.9 240.4 185.8 153.4 134.4 109.9 74.4 51.3 45.6 34.6 27.7 22.6 22.5 13.2 0.7 0.4 0.3 0.3